(PharmaNewsWire.Com, June 13, 2019 ) According to the new market research report "3D Printing Medical Devices Market by Component (3D Printers, 3D Bioprinters, Material (Plastic, Metal, Ceramic), Software & Services), Technology (EBM, LBM, Photopolymerization, 3DP, and DD), Product Type (Prosthetics, Implant) - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
The global 3D printing medical devices market is expected to reach USD 1.88 Billion by 2022 from USD 0.84 Billion in 2017, at CAGR of 17.5% from 2017 to 2022. Key factors such technological advancements, increasing public-private funding, and growing applications in the healthcare industry are the major factors driving the growth of the 3D printing medical devices market across the globe.
The global 3D printing medical devices market is segmented into three broad categories, namely, equipment, materials, and software & services. The software & services market is estimated to command the largest share of the global 3D printing medical devices market in 2017. Increasing development of advanced software solutions to manufacture high-quality 3D-printed medical products is the key factor driving the growth of the services and software segment.
Major players in 3D printing medical devices market include Stratasys, Ltd. (Israel & US), 3D Systems Corporation (US), EnvisionTEC GmbH (Germany), Materialise NV (Belgium), EOS GmbH (Germany), Arcam AB (Sweden), Concept Laser GmbH (Germany), Renishaw plc (UK), Prodways Group (France), and 3T RPD Ltd. (UK). Product approvals, launches, and acquisitions were the key strategies adopted by players to grow and expand their presence in the 3D printing medical devices market.
Major Market Developments:
+ In May 2017, Stratasys Ltd extended its strategic partnership with Desktop Metal, Inc. (US) to accelerate the adoption and accessibility of metal additive manufacturing
+ In May 2017, EnvisionTEC launched seven new materials, namely, Silicone TG, PCL 45K RG, LT Support RG, and HT Support RG for industrial and medical 3D printers
+ In June 2017, 3D Systems collaborated with rms Company (US) to develop solid organ scaffolds for human transplantation. This will help the company to strengthen its product offerings.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
